Charles River Laboratories International (CRL) News Today $162.68 +0.43 (+0.27%) As of 01:24 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Charles River Laboratories International (NYSE:CRL) Price Target Cut to $165.00 by Analysts at JPMorgan Chase & Co.JPMorgan Chase & Co. lowered their target price on shares of Charles River Laboratories International from $175.00 to $165.00 and set a "neutral" rating for the company in a research note on Thursday.February 21 at 10:57 AM | marketbeat.comCharles River Laboratories International (NYSE:CRL) Price Target Cut to $173.00 by Analysts at Robert W. BairdRobert W. Baird lowered their price target on Charles River Laboratories International from $177.00 to $173.00 and set a "neutral" rating for the company in a research report on Thursday.February 21 at 8:02 AM | marketbeat.comCharles River Laboratories International Q4 Earnings TranscriptFebruary 21 at 7:29 AM | marketbeat.comVontobel Holding Ltd. Acquires Shares of 1,817 Charles River Laboratories International, Inc. (NYSE:CRL)Vontobel Holding Ltd. acquired a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 1,817 shares of the medical research company's stock, valued at appFebruary 21 at 3:24 AM | marketbeat.comCharles River Laboratories International (NYSE:CRL) Shares Gap Up After Better-Than-Expected EarningsFebruary 21 at 1:56 AM | americanbankingnews.comCharles River Laboratories International (NYSE:CRL) Issues FY25 Earnings GuidanceCharles River Laboratories International (NYSE:CRL) updated its FY25 earnings guidance. The company provided EPS guidance of $9.10-$9.60 for the period, compared to the consensus estimate of $9.60. The company also issued revenue guidance of $3.77-$3.87 billionillion, compared to the consensus estimate of $3.87 billionillion.February 20 at 4:17 PM | marketbeat.comCharles River Labs makes good on promise to reduce headcountFebruary 20 at 2:40 PM | bizjournals.comCharles River Laboratories International (NYSE:CRL) Shares Gap Up on Earnings BeatCharles River Laboratories International (NYSE:CRL) Shares Gap Up on Strong EarningsFebruary 20 at 10:08 AM | marketbeat.comCharles River Laboratories International (NYSE:CRL) Posts Earnings Results, Beats Expectations By $0.16 EPSCharles River Laboratories International (NYSE:CRL - Get Free Report) issued its quarterly earnings results on Wednesday. The medical research company reported $2.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.50 by $0.16. Charles River Laboratories International had a net margin of 10.44% and a return on equity of 14.29%.February 20 at 8:40 AM | marketbeat.comCharles River Laboratories International (NYSE:CRL) Issues FY 2025 Earnings GuidanceCharles River Laboratories International (NYSE:CRL) updated its FY 2025 earnings guidance. The company provided EPS guidance of 9.100-9.600 for the period, compared to the consensus estimate of 9.600. The company also issued revenue guidance of $3.8 billionillion-$3.9 billionillion, compared to the consensus estimate of $3.9 billionillion.February 20 at 7:28 AM | marketbeat.comBryn Mawr Capital Management LLC Acquires 33,850 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Bryn Mawr Capital Management LLC lifted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 1,871.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 35,659 sFebruary 20 at 5:05 AM | marketbeat.comBarclays Issues Pessimistic Forecast for Charles River Laboratories International (NYSE:CRL) Stock PriceFebruary 20 at 1:59 AM | americanbankingnews.comCharles River Laboratories International, Inc. (CRL) Q4 2024 Earnings Call TranscriptFebruary 19 at 4:00 PM | seekingalpha.comCharles River Laboratories International, Inc. 2024 Q4 - Results - Earnings Call PresentationFebruary 19 at 3:04 PM | seekingalpha.comCharles River Laboratories International (NYSE:CRL) Price Target Lowered to $166.00 at BarclaysBarclays cut their price objective on Charles River Laboratories International from $205.00 to $166.00 and set an "equal weight" rating on the stock in a research report on Tuesday.February 19 at 8:20 AM | marketbeat.comCharles River beats quarterly estimates on stable demand for drug development servicesFebruary 19 at 8:11 AM | reuters.comCharles River sees FY25 EPS $9.10-$9.60, consensus $9.60February 19 at 7:54 AM | markets.businessinsider.comCharles River reports Q4 EPS $2.66, consensus $2.53February 19 at 7:54 AM | markets.businessinsider.comVenturi Wealth Management LLC Acquires 2,751 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Venturi Wealth Management LLC grew its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 170.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,367 sharesFebruary 19 at 5:07 AM | marketbeat.comCongress Asset Management Co. Sells 429,504 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Congress Asset Management Co. lessened its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 99.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owFebruary 19 at 4:12 AM | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by New York State Teachers Retirement SystemNew York State Teachers Retirement System decreased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 11.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm ownedFebruary 19 at 3:55 AM | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Short Interest UpdateCharles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) was the target of a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 2,000,000 shares, a decline of 7.4% from the January 15th total of 2,160,000 shares. Based on an average daily trading volume, of 785,400 shares, the short-interest ratio is presently 2.5 days.February 18 at 11:45 PM | marketbeat.comEarnings To Watch: Charles River Laboratories (CRL) Reports Q4 Results TomorrowFebruary 18 at 8:55 PM | msn.comEmpower Advisory Group LLC Has $50.92 Million Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)Empower Advisory Group LLC lifted its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 2.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 275,851 sharesFebruary 18 at 5:26 AM | marketbeat.comBaillie Gifford & Co. Grows Position in Charles River Laboratories International, Inc. (NYSE:CRL)Baillie Gifford & Co. raised its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 10.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 75,411 shares of tFebruary 18 at 4:50 AM | marketbeat.comVan ECK Associates Corp Has $8.93 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)Van ECK Associates Corp lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 5.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 48,380 shares of the medical research cFebruary 17, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by J.P. Marvel Investment Advisors LLCJ.P. Marvel Investment Advisors LLC cut its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 4.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 37,604 shareFebruary 16, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Buckhead Capital Management LLCBuckhead Capital Management LLC decreased its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 9.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 19,149 shares of the medical research companyFebruary 14, 2025 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Shares Acquired Rep. Julie JohnsonRepresentative Julie Johnson (D-Texas) recently bought shares of Charles River Laboratories International, Inc. (NYSE:CRL). In a filing disclosed on February 12th, the Representative disclosed that they had bought between $1,001 and $15,000 in Charles River Laboratories International stock on JanuaFebruary 14, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Acquires 47,221 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Allspring Global Investments Holdings LLC increased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 2.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 1,808,002 shares of the medical research company's stockFebruary 12, 2025 | marketbeat.comSumitomo Mitsui Trust Group Inc. Buys 13,102 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Sumitomo Mitsui Trust Group Inc. grew its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 11.7% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 125,097 shares of the medical research company's stock after aFebruary 12, 2025 | marketbeat.comMirae Asset Global Investments Co. Ltd. Buys 1,679 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Mirae Asset Global Investments Co. Ltd. grew its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 46.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,301 shares of tFebruary 12, 2025 | marketbeat.comCharles River Laboratories International, Inc. (CRL) Expands AI-Powered Digital Pathology Collaboration with DeciphexFebruary 11, 2025 | insidermonkey.comCharles River, Deciphex extend global partnershipFebruary 11, 2025 | markets.businessinsider.comCharles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management SolutionsFebruary 11, 2025 | businesswire.comCambiar Investors LLC Sells 5,880 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Cambiar Investors LLC lowered its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 12.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 40,050 shares of the medical research company'sFebruary 11, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by MADDEN SECURITIES CorpMADDEN SECURITIES Corp lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 45.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,200 shares of theFebruary 11, 2025 | marketbeat.comCharles River Laboratories International (CRL) Expected to Announce Quarterly Earnings on WednesdayFebruary 11, 2025 | americanbankingnews.comCharles River Laboratories International (NYSE:CRL) Hits New 52-Week Low - Time to Sell?Charles River Laboratories International (NYSE:CRL) Sets New 52-Week Low - Here's WhyFebruary 10, 2025 | marketbeat.comNorth Growth Management Ltd. Has $7.17 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)North Growth Management Ltd. lifted its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 18.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 39,000 shares of the medicalFebruary 9, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Robertson Stephens Wealth Management LLCRobertson Stephens Wealth Management LLC trimmed its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 78.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,921 shaFebruary 9, 2025 | marketbeat.comIridian Asset Management LLC CT Has $9.41 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL)Iridian Asset Management LLC CT cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 7.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 50,965 shares of the medical researcFebruary 7, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Given Average Rating of "Reduce" by BrokeragesShares of Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) have been assigned a consensus recommendation of "Reduce" from the seventeen research firms that are currently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a sell ratingFebruary 7, 2025 | marketbeat.comE. Ohman J or Asset Management AB Acquires 1,800 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)E. Ohman J or Asset Management AB grew its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 225.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,600 shares of thFebruary 6, 2025 | marketbeat.comTrust Point Inc. Makes New Investment in Charles River Laboratories International, Inc. (NYSE:CRL)Trust Point Inc. bought a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,045 shares oFebruary 6, 2025 | marketbeat.comCharles River price target lowered to $184 from $220 at Morgan StanleyFebruary 5, 2025 | markets.businessinsider.comMorgan Stanley Has Lowered Expectations for Charles River Laboratories International (NYSE:CRL) Stock PriceMorgan Stanley lowered their target price on shares of Charles River Laboratories International from $220.00 to $184.00 and set an "equal weight" rating on the stock in a research report on Wednesday.February 5, 2025 | marketbeat.comCharles River Laboratories International (CRL) Expected to Announce Earnings on WednesdayCharles River Laboratories International (NYSE:CRL) will be releasing earnings before the market opens on Wednesday, February 12, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=660005)February 5, 2025 | marketbeat.comCITES decision on Cambodia NHP ban positive for Charles River, says Evercore ISIFebruary 4, 2025 | markets.businessinsider.comBoston Trust Walden Corp Purchases 8,338 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Boston Trust Walden Corp boosted its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 4.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 204,483 shares of the medicalFebruary 4, 2025 | marketbeat.com Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address CRL Media Mentions By Week CRL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRL News Sentiment▼0.740.60▲Average Medical News Sentiment CRL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRL Articles This Week▼308▲CRL Articles Average Week Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mettler-Toledo International News Waters News Illumina News Bio-Techne News Bio-Rad Laboratories News Bruker News Pacific Biosciences of California News Harvard Bioscience News Thermo Fisher Scientific News Agilent Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CRL) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRL Stock Alerts